Navigation Links
Half of the people suffering from head injuries fake to receive financial help
Date:1/11/2008

This release is available in Spanish.

How can it be proved that a patient is lying when they say that they have a cognitive problem, such as memory or concentration problems or anxiety" There are many people who exaggerate their injuries and even feign them in order to receive more money from insurance companies or obtain a sick leave, according to a pioneering research in Spain. This research was carried out in the Department of Personality, Assessment and Psychological Treatment University of Granada by Doctor Raquel Vilar Lpez. The conclusions of her study, which focused on patients who suffered from head injuries, speak for themselves: nearly half of the people who go to court feign psycho-cognitive disorders with the objective of profiting from this in some way. They are not hypochondriacs or overanxious or obsessive patients, they just lie in order to receive some sort of compensation, as for example money. They are the so called simulators.

Until now, in Spain no reliable system existed to detect if a person was faking their symptoms. For this reason the study by Vilar Lpez coordinated by Manuel Gmez Ro and Miguel Prez Garca is so important: for the first time, Spanish health professionals have a set of reliable tools to prove empirically if a patient is lying when they declare, for example, that their memory problems renders them unfit for work.

Validated Evidence

The work by this researcher has validated a series of tests which, when used on patients without them being aware of it, detect which patients are simulators and which are not. These neuropsychological tests were included in a three-hour-long battery of neuropsychological tests which assesses other cognitive aspects of the patient in order to disguise the actual tests and in this way obtain the desired information.

Raquel Vilar
'/>"/>

Contact: Raquel Vilar Lpez
raquelvilarlopez@hotmail.com
34-699-407-282
Universidad de Granada
Source:Eurekalert

Page: 1 2

Related biology news :

1. Plants can be used to study how and why people respond differently to drugs
2. Fungus genome yielding answers to protect grains, people and animals
3. People who skip meals: are they better off?
4. Energy drinks may pose risks for people with high blood pressure, heart disease
5. Ozone can affect heavier people more
6. Rising food prices threaten worlds poor people
7. New study finds biodiversity conservation secures ecosystem services for people
8. 100 percent of people carry at least 1 type of pesticide
9. New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis
10. Rutgers Genetics receives $7.8 million for autism research
11. Herr receives Heinz Award for Technology, the Economy and Employment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...iation of Biology Teachers (NABT) will recognize L...ces at Naugatuck Valley Community College (NVCC) i...Education Award during the NABT annual professiona... 2009 in Denver, Colorado. , The Evolution Educa...e of Biological Sciences,(AIBS) and Biological Sc...
(Date:11/4/2009)...s in natural science) , United States Using Le...ter today than it did 35 years ago, despite a 30 p...are partly attributable to alternative cooling met... systems. According to the latest USGS water use r... States goes to cooling thermoelectric power plant...
(Date:11/4/2009)...ratory that deciphered the DNA codes, or genomes, ...rk, has joined The Genome 10K Project, an internat...DNA sequences on 10,000 species of animals for con...tly can not be achieved. , Participating in The ... in the Nov. 5, 2009 issue of the Journal of Here...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured 51923 1AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured 51923 2AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured 51923 3Reliv Internationals GlucAffect 28TM 29 Proven Effective in Clinical Study 4735 1Reliv Internationals GlucAffect 28TM 29 Proven Effective in Clinical Study 4735 2MediciGlobal Achieves Record Number of Awards 51914 1MediciGlobal Achieves Record Number of Awards 51914 2
...INDIANAPOLIS Investigators from the Herman B Well...versity School of Medicine are focusing on a famil... decreasing the toxic effects of chemotherapy in c... help in the development of targeted therapies for...he blood. , The researchers, led by Kristin T. Ch...
...esearchers from the Peninsula Medical School in Pl...s the one hour of moderate exercise a day recommen...ugh to tackle the rising problem of childhood obes...ost recent issue of the journal "Archives of Disea...rlyBird study, which has followed the development ...
...0 October 2008.- During the 1950s, Austrian and Sw...Everest region in Nepal taking photographs of the ...ime, the Swiss glaciologist Fritz Mller spent eigh...res, studying and photographing the Himalayan glac...te photographs taken by these scientists are of im...
Other Biology News:On the trail of a targeted therapy for blood cancers 2Recommendations for children's exercise lacking say experts 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3
(Date:11/6/2009)...ire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE:...John Docherty, president and chief operating offic...ual Investor Summit on November 10, 2009 at 4:00 P...erty will provide an overview of the Company,s lea...cal Interferon Alpha-2b. The slide show portion o...
(Date:11/6/2009)...swire-FirstCall/ -- ,, 3Q09 Corporate Highli....U. Marketing Authorization to Astellas Pharma Eur... readiness activities Expanded management team to... Director, Commercial Operations Appointed Bradfo...ttee chairman , Upcoming 2009 Milestones: ...
(Date:11/6/2009)...ire/ -- Intarcia Therapeutics, Inc. delivered two ...ontinuous delivery of exenatide) program for the t...abetes Technology Meeting in San Francisco, CA: ,...050301/SFTU126LOGO ) ,, Continuous Subcutaneo...a Glucose, HbA1c and Reduces Weight in a 28-day Ph...
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...leading biomedical and allograft agency, announces...cal Systems International, Inc.), the,InstrumentRe...LifeNet,Health customers, improving the tracking o...r the development, marketing, distribution, and,su...issue tracking,software. The new software will hel...
...g the,economic and business growth in the Tampa Ba...nches First Major Project to Improve Port Security... $36.5 million contract,to develop a Maritime Doma...sensing and situation awareness technologies for i...ontract was awarded to SRI by the U.S. Naval Air,S...
...f Standards and Technology (NIST) have a mechanica...orted values for other nanoscale devices such as c...ial quartz crystals. Because a high Q factor indic...es might be used as oscillators in nano-electromec...ications devices. , We think the most interesting...
Other Biology Technology:LifeNet Health and IMS Announce Partnership 2Highlights of Economic and Business Growth in the Tampa Bay Region 2Highlights of Economic and Business Growth in the Tampa Bay Region 3Highlights of Economic and Business Growth in the Tampa Bay Region 4'High Q' NIST nanowires may be practical oscillators 2
...hemical Inkjet Printer) is a revolutionary new app...acroarray Analysis, developed in conjunction with ...trategy compliments established protocols in resol...lectric point and apparent molecular weight). Howe...
RNase Inhibitor from Applied Biosystems
Goat Anti-Rat UGT1A7 (E-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)
Biology Products: